Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab and COVID-19 vaccination
TCTR20221213001Completed
- Sponsor
- Division of Dermatology, Department of Internal Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University
- Start
- Aug 2022
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Trial of rituximab in coronavirus disease 2019 (COVID-19), sponsored by Division of Dermatology, Department of Internal Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University. Started Aug 2022; status: completed.
02
Drugs
rituximab
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on TCTR20221213001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20221213001.